Three-phase bone scintigraphy can predict the analgesic efficacy of ketamine therapy in CRPS
Clinical Journal of Pain Aug 21, 2018
Sorel M, et al. - Researchers investigated assessed the value of three-phase bone scintigraphy (TPBS) to predict the analgesic efficacy of ketamine therapy in complex regional pain syndrome (CRPS). They observed a positive correlation of the relative hyperfixation of the radioactive tracer in the limb region concerned by CRPS in phases 2 and 3 vs phase 1 of TPBS, with the analgesic efficacy of ketamine. For the first time, TPBS was shown to have potential predictive value regarding ketamine therapy outcome. Findings suggested the possible involvement of “peripheral” mechanisms related to tissue inflammation and bone remodeling in the analgesic action of ketamine; these were not restricted to “central” mechanisms.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries